MIRA Pharmaceuticals (MIRA) Stock Chart & Stock Price History $1.04 +0.05 (+4.61%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$1.04 +0.00 (+0.48%) As of 04/25/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA Pharmaceuticals Stock Price Performance 5 Day Performance+20.23%1 Month Performance-9.57%3 Month Performance-8.77%6 Month Performance-19.38%Year-To-Date Performance-8.77%1 Year Performance+20.96% Receive MIRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address MIRA Stock Chart for Saturday, April, 26, 2025 MIRA Chart by TradingView MIRA Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025$0.99$1.04+4.61%$1.08$0.98627,287 shs$17.49 million04/24/2025$0.92$0.99+7.95%$1.03$0.90697,645 shs$16.72 million04/23/2025$0.86$0.92+7.08%$0.99$0.844.78 million shs$15.49 million04/22/2025$0.87$0.86-0.57%$0.89$0.84296,936 shs$14.46 million04/21/2025$0.94$0.87-7.87%$0.94$0.86397,237 shs$14.54 million04/18/2025$0.94$0.94$0.99$0.831.81 million shs$15.79 million04/17/2025$1.07$0.94-12.25%$0.99$0.831.81 million shs$15.79 million04/16/2025$0.90$1.07+19.26%$1.33$0.9947.91 million shs$17.99 million04/15/2025$0.89$0.90+0.81%$0.90$0.8957,240 shs$15.09 million04/14/2025$0.86$0.89+2.90%$0.90$0.8788,493 shs$14.96 million Get the Latest News and Ratings for MIRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025$0.84$0.86+2.52%$0.89$0.8459,584 shs$14.54 million04/10/2025$0.85$0.84-0.17%$0.86$0.8257,293 shs$14.18 million04/09/2025$0.83$0.85+1.81%$0.87$0.7878,292 shs$14.21 million04/09/2025$0.83$0.85+1.81%$0.87$0.7878,292 shs$14.21 million04/08/2025$0.80$0.83+3.39%$0.87$0.81119,585 shs$13.96 million04/08/2025$0.80$0.83+3.39%$0.87$0.81119,585 shs$13.96 million04/07/2025$0.83$0.80-3.79%$0.84$0.73299,376 shs$13.50 million04/04/2025$0.90$0.83-7.29%$0.94$0.81134,324 shs$14.03 million04/03/2025$0.95$0.90-5.06%$0.97$0.87140,224 shs$14.91 million04/02/2025$0.96$0.95-0.73%$1.00$0.93160,646 shs$15.70 million04/01/2025$0.98$0.96-2.55%$1.00$0.95124,921 shs$15.82 million03/31/2025$1.06$0.98-7.55%$1.05$0.98173,446 shs$16.23 million03/28/2025$1.10$1.06-3.64%$1.11$1.0682,136 shs$17.56 million03/27/2025$1.15$1.10-4.35%$1.17$1.0969,365 shs$18.22 million03/26/2025$1.22$1.15-5.74%$1.22$1.06326,236 shs$19.05 million03/25/2025$1.23$1.22-0.81%$1.24$1.18234,941 shs$20.20 million Related Companies PMV Pharmaceuticals Stock Chart Assertio Stock Chart Adverum Biotechnologies Stock Chart Kronos Bio Stock Chart Ikena Oncology Stock Chart Medicus Pharma Stock Chart Precision BioSciences Stock Chart BeyondSpring Stock Chart Milestone Pharmaceuticals Stock Chart FibroBiologics Stock Chart Receive MIRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MIRA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
